These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3385780)

  • 1. Evidence that glutathione may determine the differential cell-cycle phase toxicity of a platinum (IV) antitumor agent.
    Edwards PG
    J Natl Cancer Inst; 1988 Jul; 80(10):734-8. PubMed ID: 3385780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
    Meijer C; Mulder NH; Timmer-Bosscha H; Sluiter WJ; Meersma GJ; de Vries EG
    Cancer Res; 1992 Dec; 52(24):6885-9. PubMed ID: 1458477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of thiols in cellular response to radiation and drugs.
    Biaglow JE; Varnes ME; Clark EP; Epp ER
    Radiat Res; 1983 Sep; 95(3):437-55. PubMed ID: 6684310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of antitumor disulfide cytotoxicity by glutathione depletion in murine cells.
    Kirkpatrick DL
    Cancer Res; 1987 Aug; 47(16):4391-5. PubMed ID: 3607770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
    Bertsche U; Schorn H
    Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione depletion, radiosensitization, and misonidazole potentiation in hypoxic Chinese hamster ovary cells by buthionine sulfoximine.
    Clark EP; Epp ER; Biaglow JE; Morse-Gaudio M; Zachgo E
    Radiat Res; 1984 May; 98(2):370-80. PubMed ID: 6539482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular glutathione as a protective agent against 4-hydroperoxycyclophosphamide cytotoxicity in K-562 cells.
    Peters RH; Ballard K; Oatis JE; Jollow DJ; Stuart RK
    Cancer Chemother Pharmacol; 1990; 26(6):397-402. PubMed ID: 2225310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase.
    Messina JP; Lawrence DA
    J Immunol; 1989 Sep; 143(6):1974-81. PubMed ID: 2789253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glutathione depletion on the cytotoxicity of cisplatin and iproplatin in a human melanoma cell line.
    Pendyala L; Perez R; Weinstein A; Zdanowicz J; Creaven PJ
    Cancer Chemother Pharmacol; 1997; 40(1):38-44. PubMed ID: 9137527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione levels in cultured heart cells. Influence of buthionine sulfoximine, an inhibitor of glutathione synthesis.
    Lewko WM
    Biochem Pharmacol; 1987 Jan; 36(2):219-23. PubMed ID: 3814167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts.
    Goddard P; Valenti M; Kelland LR
    Anticancer Res; 1994; 14(3A):1065-70. PubMed ID: 8074451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion.
    Andrews PA; Murphy MP; Howell SB
    Cancer Res; 1985 Dec; 45(12 Pt 1):6250-3. PubMed ID: 4063975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio.
    Mitchell JB; Russo A; Biaglow JE; McPherson S
    Radiat Res; 1983 Nov; 96(2):422-8. PubMed ID: 6647769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of glucose in cellular defences against cytotoxicity of hydrogen peroxide in Chinese hamster ovary cells.
    Averill-Bates DA; Przybytkowski E
    Arch Biochem Biophys; 1994 Jul; 312(1):52-8. PubMed ID: 8031146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric analysis of protein thiol groups in relation to the cell cycle and the intracellular content of glutathione in rat hepatocytes.
    Principe P; Wilson GD; Riley PA; Slater TF
    Cytometry; 1989 Nov; 10(6):750-61. PubMed ID: 2582966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of intracellular glutathione in antineoplastic chemotherapy.
    Russo A; Carmichael J; Friedman N; DeGraff W; Tochner Z; Glatstein E; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1347-54. PubMed ID: 3531114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of glutathione and related enzymes in reversal of resistance to anticancer drugs.
    O'Dwyer PJ; Hamilton TC; Yao KS; Tew KD; Ozols RF
    Hematol Oncol Clin North Am; 1995 Apr; 9(2):383-96. PubMed ID: 7642469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro study comparing the cytotoxicity of three platinum complexes with regard to the effect of thiol depletion.
    Smith E; Brock AP
    Br J Cancer; 1988 Jun; 57(6):548-52. PubMed ID: 3044430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione conjugation and induction of a 32,000 dalton stress protein.
    Freeman ML; Meredith MJ
    Biochem Pharmacol; 1989 Jan; 38(2):299-304. PubMed ID: 2914013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
    Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.